Find Clinical Trial

Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.


← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

IndicationHypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

AMLODIPINE, PERINDOPRIL ARGININE,
S005985

Active Substance CodeS005985
Protocol CodeCL3-05985-018
EudraCT Code2010-020945-28
ISRCTN CodeISRCTN59214686


Documents and links

Results summary READ MORE
Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility